[Abstract] Int J Pept Res Ther
These may include: Injection site reactions: Prolonged use of injections can cause persistent redness, swelling, or pain at the injection site
One of the most commonly studied weight-loss drugs, GLP-1RAs, were initially developed to treat T2D by reducing postprandial glucose excursions, augmenting glucose-dependent insulin release, inhibiting glucagon secretion and delaying gastric emptying (136, 137)
If someone is pregnant or breastfeeding or has a personal or family history of medullary thyroid cancer, they should consider them off limits
Dosing convenience: MariTide, from Amgen, uses once-monthly subcutaneous dosing rather than weekly injections
Verify your Part D plans formulary find out if your specific drug is covered under your plan, what tier, what your copays/deductibles will be, and what prior authorizations are required